Literature DB >> 21151428

Adopting postoperative chemoradiotherapy in resected gastric cancer.

John S Macdonald1.   

Abstract

Entities:  

Year:  2009        PMID： 21151428      PMCID： PMC3000071     

Source DB:  PubMed          Journal:  Gastrointest Cancer Res        ISSN： 1934-7820


× No keyword cloud information.
  7 in total

1.  Underrepresentation of patients 65 years of age or older in cancer-treatment trials.

Authors:  L F Hutchins; J M Unger; J J Crowley; C A Coltman; K S Albain
Journal:  N Engl J Med       Date:  1999-12-30       Impact factor: 91.245

2.  A pooled analysis of adjuvant chemotherapy for resected colon cancer in elderly patients.

Authors:  D J Sargent; R M Goldberg; S D Jacobson; J S Macdonald; R Labianca; D G Haller; L E Shepherd; J F Seitz; G Francini
Journal:  N Engl J Med       Date:  2001-10-11       Impact factor: 91.245

3.  Chemoradiotherapy after surgery compared with surgery alone for adenocarcinoma of the stomach or gastroesophageal junction.

Authors:  J S Macdonald; S R Smalley; J Benedetti; S A Hundahl; N C Estes; G N Stemmermann; D G Haller; J A Ajani; L L Gunderson; J M Jessup; J A Martenson
Journal:  N Engl J Med       Date:  2001-09-06       Impact factor: 91.245

4.  A population-based analysis of surgical and adjuvant therapy for resected gastric cancer: are patients receiving appropriate treatment following publication of the intergroup 0116 results?

Authors:  C Kristian Enestvedt; Brian S Diggs; Donald K Shipley; Charles R Thomas; Kevin G Billingsley
Journal:  Gastrointest Cancer Res       Date:  2009-11

5.  Extended lymph node dissection for gastric cancer: who may benefit? Final results of the randomized Dutch gastric cancer group trial.

Authors:  H H Hartgrink; C J H van de Velde; H Putter; J J Bonenkamp; E Klein Kranenbarg; I Songun; K Welvaart; J H J M van Krieken; S Meijer; J T M Plukker; P J van Elk; H Obertop; D J Gouma; J J B van Lanschot; C W Taat; P W de Graaf; M F von Meyenfeldt; H Tilanus; M Sasako
Journal:  J Clin Oncol       Date:  2004-04-13       Impact factor: 44.544

6.  Lymph node staging standards in gastric cancer.

Authors:  A M Bunt; P C Hogendoorn; C J van de Velde; J A Bruijn; J Hermans
Journal:  J Clin Oncol       Date:  1995-09       Impact factor: 44.544

7.  Effect of microscopic resection line disease on gastric cancer survival.

Authors:  S H Kim; M S Karpeh; D S Klimstra; D Leung; M F Brennan
Journal:  J Gastrointest Surg       Date:  1999 Jan-Feb       Impact factor: 3.267
  7 in total
  2 in total

1.  Timing of chemotherapy and survival in patients with resectable gastric adenocarcinoma.

Authors:  Amanda K Arrington; Rebecca Nelson; Supriya S Patel; Carrie Luu; Michelle Ko; Julio Garcia-Aguilar; Joseph Kim
Journal:  World J Gastrointest Surg       Date:  2013-12-27

2.  Quality of life in patients with advanced gastric cancer sequentially treated with docetaxel and irinotecan with 5-fluorouracil and folinic acid (leucovin).

Authors:  M Gubanski; B Glimelius; P A Lind
Journal:  Med Oncol       Date:  2014-03-14       Impact factor: 3.064
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.